The Highs and Lows of Cardiac Troponin: What Your High Sensitivity Assay Is Measuring and What Might It Be Missing?

Tuesday, July 30
7:00 a.m. – 8:30 a.m.
Location: Hyatt Regency McCormick Place
Room: Regency Ballroom C-E
Sponsored by Abbott


High sensitivity (hs) cardiac troponin assays have revolutionized the care of patients with suspected myocardial infarction, allowing for faster triage and more accurate diagnostic protocols. However, interpretation of cardiac troponin results requires consideration of patient and assay specific factors. This expert led session will cover analytical and clinical aspects across high and low hs-cardiac troponin results, while covering factors that may lead to potential misdiagnosis of myocardial infarction.


Gillian Murtagh, MD, MBA
Director of Systems, Cardiology / Pulmonology
Medical and Scientific Affairs
Core Diagnostics


Fred S. Apple PhD, DABCC
Medical Director Clinical & Forensic Toxicology, Laboratory Medicine & Pathology, Hennepin Healthcare/Hennepin County Medical Center
Principal Investigator, Cardiac Biomarkers Trials Laboratory & Hennepin Healthcare Research Institute
Professor, Laboratory Medicine & Pathology, University of Minnesota

Christopher W. Farnsworth, PhD, DABCC, FADLM
Associate Professor, Pathology & Immunology
Section Head, Clinical Chemistry
Co-Director, Clinical Chemistry Fellowship
Washington University in St. Louis